- Home
- TNON
TNON
Tenon Medical Inc.
as of 09-22-2026 10:46am EST
Tenon Medical Inc is a medical device company that has minimally invasive approach to the sacroiliac joint (the SI Joint) using a single, robust, titanium implant for the treatment of the common types of SI Joint disorders that cause lower back pain. The Company is focused on three commercial opportunities; Primary SI Joint procedures, Revision procedures of failed SI Joint implants, and SI Joint fusion adjunct to a spine fusion construct. The company derives the majority of its revenue from sales of The Catamaran System to a limited number of clinicians.
| Founded: | 2012 | Country: | United States |
| Employees: | N/A | City: | LOS GATOS |
| Market Cap: | 2.8M | IPO Year: | 2021 |
| Target Price: | N/A | AVG Volume (30 days): | 9.3M |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | N/A | Dividend Payout Frequency: | annual |
| EPS: | -23.16 | EPS Growth: | 84.90 |
| 52 Week Low/High: | $0.13 - $17.84 | Next Earning Date: | 05-05-2026 |
| Revenue: | $3,944,000 | Revenue Growth: | 20.35% |
| Revenue Growth (this year): | 65.95% | Revenue Growth (next year): | 50.54% |
| P/E Ratio: | -0.16 | Index: | N/A |
| Free Cash Flow: | -11018000.0 | FCF Growth: | N/A |
AI-Powered TNON Daily Prediction
Machine learning model trained on 25+ technical indicators
AI Recommendation
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
Stock Insider Trading Activity of Tenon Medical Inc. (TNON)
10% Owner
Avg Cost/Share
$3.95
Shares
67,925
Total Value
$246,296.70
Owned After
15,839
10% Owner
Avg Cost/Share
$5.56
Shares
65,582
Total Value
$364,635.92
Owned After
15,839
SEC Form 4
10% Owner
Avg Cost/Share
$3.40
Shares
39,508
Total Value
$134,327.20
Owned After
15,839
SEC Form 4
10% Owner
Avg Cost/Share
$3.44
Shares
60,343
Total Value
$174,008.91
Owned After
15,839
10% Owner
Avg Cost/Share
$3.34
Shares
707
Total Value
$2,361.38
Owned After
15,839
SEC Form 4
10% Owner
Avg Cost/Share
$3.70
Shares
1,506
Total Value
$5,572.20
Owned After
15,839
SEC Form 4
10% Owner
Avg Cost/Share
$3.98
Shares
1,658
Total Value
$6,598.84
Owned After
15,839
SEC Form 4
10% Owner
Avg Cost/Share
$4.53
Shares
450
Total Value
$2,038.50
Owned After
15,839
SEC Form 4
10% Owner
Avg Cost/Share
$4.57
Shares
1,790
Total Value
$8,180.30
Owned After
15,839
SEC Form 4
10% Owner
Avg Cost/Share
$4.66
Shares
1,276
Total Value
$5,946.16
Owned After
15,839
SEC Form 4
| Insider | Ticker | Relationship | Date | Transaction | Avg Cost | Shares | Total Value | Owned After | SEC Forms |
|---|---|---|---|---|---|---|---|---|---|
| HRT FINANCIAL LP | TNON | 10% Owner | Sep 10, 2026 | Buy | $3.95 | 67,925 | $246,296.70 | 15,839 | |
| HRT FINANCIAL LP | TNON | 10% Owner | Sep 10, 2026 | Sell | $5.56 | 65,582 | $364,635.92 | 15,839 | |
| HRT FINANCIAL LP | TNON | 10% Owner | Sep 9, 2026 | Buy | $3.40 | 39,508 | $134,327.20 | 15,839 | |
| HRT FINANCIAL LP | TNON | 10% Owner | Sep 9, 2026 | Sell | $3.44 | 60,343 | $174,008.91 | 15,839 | |
| HRT FINANCIAL LP | TNON | 10% Owner | Sep 8, 2026 | Buy | $3.34 | 707 | $2,361.38 | 15,839 | |
| HRT FINANCIAL LP | TNON | 10% Owner | Sep 4, 2026 | Sell | $3.70 | 1,506 | $5,572.20 | 15,839 | |
| HRT FINANCIAL LP | TNON | 10% Owner | Sep 3, 2026 | Buy | $3.98 | 1,658 | $6,598.84 | 15,839 | |
| HRT FINANCIAL LP | TNON | 10% Owner | Sep 2, 2026 | Sell | $4.53 | 450 | $2,038.50 | 15,839 | |
| HRT FINANCIAL LP | TNON | 10% Owner | Sep 1, 2026 | Buy | $4.57 | 1,790 | $8,180.30 | 15,839 | |
| HRT FINANCIAL LP | TNON | 10% Owner | Aug 31, 2026 | Sell | $4.66 | 1,276 | $5,946.16 | 15,839 |
Earnings Transcripts
SEC 8-K filings with transcript text
2026 Q2 Q2 2026 Earnings
8-K SELL Aug 13, 2026 · 100% conf.
Q2 2026 Earnings
8-K SELLAug 13, 2026 · 100% conf.
1D
-5.50%
$5.63
Act: -13.42%
5D
-9.99%
$5.36
20D
-18.82%
$4.84
Transcript text not available. View on SEC.gov →
2026 Q1 Q1 2026 Earnings
8-K May 12, 2026
Q1 2026 Earnings
8-KMay 12, 2026
2025 Q4 Q4 2025 Earnings
8-K Mar 19, 2026
Q4 2025 Earnings
8-KMar 19, 2026
Compare TNON vs Leading Stocks
See how TNON stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "TNON Tenon Medical Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.